<DOC>
	<DOCNO>NCT02021253</DOCNO>
	<brief_summary>Surgical resection one curative treatment modality HCC . Limits postoperative septic liver functional complication related increase bacterial translocation systemic endotoxemia . Bacterial translocation passage bacteria bacterial degradation product intestine portal circulation . The endotoxemia secondary bacterial translocation , stimulate endothelial production nitric oxide ( NO ) . NO also potent inducer membrane instability , responsible increase permeability vascular endothelium intestinal mucosa , possibly contribute worsen bacterial translocation . Probiotics live microorganism administer adequate amount , provide health benefit host ( ( Health Nutritional Properties Probiotics Food Including Powder Milk Live Lactic Acid Bacteria - Cordoba Argentina October 2001 ) . Data experimental clinical literature show significant effect probiotic improvement liver function decrease infectious complication patient chronic liver disease . The propose study would evaluate effect preventive therapeutic population surgical patient , intestinal portal hepatic inflammation promotes postoperative complication .</brief_summary>
	<brief_title>Influence Probiotics Administration Before Liver Resection Liver Disease</brief_title>
	<detailed_description>The aim study evaluate effect administration probiotic intestinal barrier function patient chronic liver disease ( fibrosis stage F3 F4 ) operate hepatocellular carcinoma . After hepatectomy , kinetic endotoxemia study previously evolution summarize area plasma concentration versus time curve ( AUC ) circulate endotoxin level measure surgery 5 different time analysis hepatectomy . At 12 hour , portal hypertension consequence gut permeability ( impaired barrier function , bacterial translocation ) high peak circulating endotoxin . The decrease endotoxemia curve observe 2nd 3rd day ( end liver regeneration early liver architectural reorganization ) . On 5th day , persist measurable deleterious liver restructure theoretically functional rate . Then main criterion demonstrate effectiveness diet enrich probiotic AUC circulating level endotoxin ( ( pg/ml ) use Limulus amebocyte lysate ( LAL ) assay ) observe patient . Endotoxin level analyse sample peripheral blood . The two arm equal size consider significantly different compare AUC circulating level endotoxin null hypothesis ( AUC arm ) reject favor alternative hypothesis ( AUC differs two arm - Wilcoxon test ) In order estimate sample size distinguish two hypothesis sufficient power , median AUC arm without probiotic use form two group patient arm . Thus , half patient without probiotic high median AUC arm . Then , proportion may compare proportion patient probiotic AUC great median group without probiotic . The secondary endpoint : - Evaluation systemic inflammation assay inflammatory cytokine - IL-2 , IL-4 , IL-6 , IL-8 , IL-10 , GM-CSF , IFNa , TNFa - CRP - Leukocyte count - The post-operative liver function monitor usual manner - Standard Liver function test J1 J5 ( Bilirubin , prothrombin , ammonia ) - Indocyanine green clearance measure retention rate 15 minute J1 J3 - Monitoring overall postoperative complication specifically liver failure infectious complication 3 month .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Agreement sign patient Diagnosis HCC confirm Diagnosis liver disease ( score F3 F4 ) confirm Indication surgical resection confirm validated specialist multidisciplinary assessment meeting gastrointestinal oncology Patient operable ( indication anaesthesiological ) Resectable tumor lesion ( surgical expertise ) Laboratory test endoscopy : No suspicion severe portal hypertension bleed risk Patient willing , risk default compliance , patient monitor regularly Antibiotic extend terminate less 1 month , may limit effect take probiotic . Inflammatory Bowel Disease , could skew result expect take probiotic result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Endotoxemia</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Leaky gut</keyword>
	<keyword>Gut permeability</keyword>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Liver fibrosis</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
</DOC>